Exercise-induced bronchoconstriction: Diagnosis and management

American Family Physician

Volumn 84, Issue 4, 2011, Pages 427-434

  Krafczyk, Michael A ^a   Asplund, Chad A ^b  

^a ST LUKE S HOSPITAL   (United States)

^b EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; FORMOTEROL FUMARATE; FUROSEMIDE; HEPARIN; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; MOMETASONE FUROATE; MONTELUKAST; OMEGA 3 FATTY ACID; PIRBUTEROL ACETATE; SALBUTAMOL; SALMETEROL XINAFOATE; SODIUM CHLORIDE; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHOSPASM; CHEST TIGHTNESS; COUGHING; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EXERCISE; EXERCISE INDUCED BRONCHOSPASM; EXERCISE TEST; FATIGUE; HEAT EXCHANGE; HUMAN; HYPERPNEA; INHALATION TEST; LUNG MINUTE VOLUME; MASK; SINGLE DRUG DOSE; SPIROMETRY; SYMPTOM; WHEEZING;

EID: 80051710002     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Randolph C. An update on exercise-induced bronchoconstriction with and without asthma. Curr Allergy Asthma Rep. 2009;9(6):433-438.
2. Managing asthma long term-special situations. In: National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH publication no. 07-4051. Bethesda, Md.: National Heart, Lung, and Blood Institute; 2007:363-372. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed May 3, 2010.
3. Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest. 2005;128(6):3966-3974.
4. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc. 2000;32(4):732-737.
5. Weiler JM, Bonini S, Coifman R, et al.; Ad Hoc Committee of Sports Medicine Committee of American Academy of Allergy, Asthma & Immunology. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119(6):1349-1358.
6. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39(9):1487-1492.
7. De Baets F, Bodart E, Dramaix-Wilmet M, et al. Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction. Pediatr Pulmonol. 2005;39(4):301-305.
8. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33(2):208-213.
9. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122(2):238-246.
10. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: Challenges for diagnosis. J Allergy Clin Immunol. 2002;110(3):374-380.
11. Weiss P, Rundell KW. Imitators of exercise-induced bronchoconstriction. Allergy Asthma Clin Immunol. 2009;5(1):7.
12. Hallstrand TS, Curtis JR, Aitken ML, Sullivan SD. Quality of life in adolescents with mild asthma. Pediatr Pulmonol. 2003;36(6):536-543.
13. Becker JM, Rogers J, Rossini G, et al. Asthma deaths during sports: report of a 7-year experience. J Allergy Clin Immunol. 2004;113(2):264-267.
14. Dryden DM, Spooner CH, Stickland MK, et al. Exercise-induced bronchoconstriction and asthma. Evidence Reports/Technology Assessments, no. 189. AHRQ publication no. 10-E001. Rockville, Md.: Agency for Healthcare Research and Quality; January 2010.
15. Rundell KW, Wilber RL, Szmedra L, Jenkinson DM, Mayers LB, Im J. Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge. Med Sci Sports Exerc. 2000;32(2):309-316.
16. Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest. 2006;129(5):1188-1193.
17. Mickleborough TD. Salt intake, asthma, and exercise-induced bronchoconstriction: a review. Phys Sportsmed. 2010;38(1):118-131.
18. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006;129(1):39-49.
19. Physicians' Desk Reference. 64th ed. Montvale, N.J.: Physicians' Desk Reference, Inc.; 2010.
20. Sinha T, David AK. Recognition and management of exercise-induced bronchospasm. Am Fam Physician. 2003;67(4):769-774.
21. Medications. In: National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH publication no. 07-4051. Bethesda, Md.: National Heart, Lung, and Blood Institute; 2007:213-276. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed May 3, 2010.
22. U.S. Food and Drug Administration. FDA announces new safety controls for long-acting beta agonists, medications used to treat asthma. February 18, 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm200931.htm. Accessed May 3, 2010.
23. Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pediatr Pulmonol. 2009;44(5):429-435.
24. Spooner CH, Spooner GR, Rowe BH. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev. 2003;(4):CD002307.
25. Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev. 2007;(3):CD002739.
26. Coreno A, et al. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol. 2000;106(3):500-506.
27. Philip G, Pearlman DS, Villarán C, et al. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest. 2007;132(3):875-883.
28. Raissy HH, Harkins M, Kelly F, Kelly HW. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children. Pharmacotherapy. 2008;28(3):287-294.
29. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med. 2000;132(2):97-104.
30. Ahmed T, Gonzalez BJ, Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am J Respir Crit Care Med. 1999;160(2):576-581.
31. Melo RE, Solé D, Naspitz CK. Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol. 1997;99(2):204-209.
32. National Collegiate Athletic Association. NCAA banned drug list. http://www.ncaa.org/wps/wcm/connect/public/NCAA/Student-Athlete+Experience/NCAA+banned+drugs+list. Accessed May 3, 2010.
33. World Anti-Doping Agency. The World Anti-Doping Code: The 2010 Prohibited List: International Standard. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf. Accessed May 3, 2010.